NDC 76413-317

Zantac

Ranitidine

Zantac is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by Central Texas Community Health Centers. The primary component is Ranitidine Hydrochloride.

Product ID76413-317_5a3058ab-e988-4010-99df-ee481cdd862c
NDC76413-317
Product TypeHuman Otc Drug
Proprietary NameZantac
Generic NameRanitidine
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2006-12-21
Marketing CategoryNDA / NDA
Application NumberNDA020520
Labeler NameCentral Texas Community Health Centers
Substance NameRANITIDINE HYDROCHLORIDE
Active Ingredient Strength75 mg/1
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 76413-317-30

3 BLISTER PACK in 1 CARTON (76413-317-30) > 10 TABLET, COATED in 1 BLISTER PACK
Marketing Start Date2006-12-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 76413-317-30 [76413031730]

Zantac TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020520
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-12-21
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
RANITIDINE HYDROCHLORIDE75 mg/1

OpenFDA Data

SPL SET ID:2e846995-48b9-4062-b6f7-46884d411039
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 312773
  • 827183

    • NDC Crossover Matching brand name "Zantac" or generic name "Ranitidine"

    NDCBrand NameGeneric Name
    0173-0393ZANTACranitidine hydrochloride
    76413-317ZantacZantac
    52565-101ZANTACZANTAC
    52565-096ZANTACZANTAC
    52565-102ZANTACZANTAC
    10202-8527 Select Acid ReducerRanitidine
    0904-6350Acid ReducerRanitidine
    0113-7950basic care acid reducerRanitidine
    0113-7852basic care acid reducer 150Ranitidine
    0113-7876basic care acid reducer 75Ranitidine
    0113-0852Good Sense Acid ReducerRanitidine
    0113-0876Good Sense Acid ReducerRanitidine
    10202-712MAXIMUM STRENGTH RANITIDINERanitidine
    0597-0121Maximum Strength Zantacranitidine
    0121-0727RanitidineRANITIDINE
    0121-4727RanitidineRANITIDINE
    0172-4357RanitidineRanitidine
    0172-4358RanitidineRanitidine
    0363-0352RanitidineRanitidine
    0440-8300RanitidineRanitidine
    0440-8305RanitidineRanitidine
    0615-4513RanitidineRanitidine
    0615-4514RanitidineRanitidine
    0615-8021RanitidineRanitidine
    0781-6087RanitidineRanitidine
    0904-6349RanitidineRanitidine
    0904-6716RanitidineRanitidine
    0904-6921RanitidineRanitidine
    10544-056RanitidineRanitidine
    10544-438RanitidineRanitidine
    10544-516RanitidineRanitidine
    0904-6715ranitidine 75Ranitidine
    11673-023up and up ranitidineRanitidine
    0363-0852wal zan 150Ranitidine
    0363-0950wal zan 150Ranitidine
    0363-1876wal zan 75Ranitidine
    0363-0362Wal-ZanRanitidine
    0597-0122Zantac 75ranitidine
    0597-0120Zantac Maximum Strength 150 Cool Mintranitidine

    Trademark Results [Zantac]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ZANTAC
    ZANTAC
    74504090 1967301 Live/Registered
    BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
    1994-03-23
    ZANTAC
    ZANTAC
    74504089 1965943 Live/Registered
    BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
    1994-03-23
    ZANTAC
    ZANTAC
    74136868 1865140 Dead/Cancelled
    GLAXO GROUP LIMITED
    1991-02-06
    ZANTAC
    ZANTAC
    74103235 1685021 Live/Registered
    CHATTEM, INC.
    1990-10-04
    ZANTAC
    ZANTAC
    74010111 not registered Dead/Abandoned
    GLAXO GROUP LIMITED
    1989-12-12
    ZANTAC
    ZANTAC
    73804230 not registered Dead/Abandoned
    GLAXO GROUP LIMITED
    1989-06-05
    ZANTAC
    ZANTAC
    73337687 1230799 Dead/Cancelled
    Glaxo Group Limited
    1981-11-18
    ZANTAC
    ZANTAC
    73289054 1220525 Live/Registered
    Glaxo Group Limited
    1980-12-09
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.